Unlocking the future of healthcare:
The EU Health Technology Assessment (HTA) journey
As the European Union takes bold strides towards harmonizing and enhancing its healthcare landscape, the implementation of the Joint Clinical Assessment (JCA) stands as a pivotal moment. At Cencora, we help companies at all stages of the EU HTA journey, from early evidence to post-JCA implementation at the national level.
Our EU HTA Center of Excellence brings together expert domain leaders with deep knowledge of the intricacies of this complex initiative. Unveiling the path forward, our experts offer unparalleled insights into the current status of EU HTA, shed light on the uncertainties that lie ahead, and equip you with solutions to help you navigate this transformative landscape.
Our EU HTA Center of Excellence brings together expert domain leaders with deep knowledge of the intricacies of this complex initiative. Unveiling the path forward, our experts offer unparalleled insights into the current status of EU HTA, shed light on the uncertainties that lie ahead, and equip you with solutions to help you navigate this transformative landscape.
EU HTA Center of Excellence
500+
HTA submissions delivered across Europe over the last 5 years
250+
HTA, RWE, and market access consultants across Europe
One expert partner, from early evidence advice to post-JCA implementation
Cencora helps deliver an optimized JCA by providing specialist capabilities, robust capacity, and strategic partnership.
Readiness
- Affiliate activation and engagement models
- Education and awareness initiatives
- Organisational audit and change management
Strategy
- Joint scientific consultation (JSC)
- Early evidence planning
- PICO simulation
- Core HTA strategy and EU launch planning
Implementation
- Evidence review
Statistical analysis
- JCA submission writing
- Post-JCA implementation support
Explore our latest insights
Meet Ruairi O’Donnell, EU HTA Lead at Cencora
A 20-year veteran of the global market access and HEOR consulting services sector, Ruairi has held numerous leadership positions in leading global consulting organizations, with a strong background in value strategy, evidence development, and market access pathways. Prior to taking on his role as EU HTA lead for Cencora, he was Senior Director of Evidence Generation and Value Communications.
Watch our latest webinars
Contact us today
Pardot Form
Explore more
Stay informed about the latest insights on EU Health Technology Assessment (HTA). Explore our additional resources below to enhance your knowledge and understanding.
